Showing results (1-10 of 367) with videos related to
Sort By:
Pageof 37
British Journal of Cancer|February 6, 2003
Metastatic renal carcinoma comprehensive prognostic systemJ Atzpodien, P Royston, T Wandert, et al.Critical Reviews in Oncology/Hematology|August 24, 2005
Age does not impair the efficacy of immunochemotherapy in patients with metastatic renal carcinomaJ Atzpodien, T Wandert, M ReitzBritish Journal of Cancer|July 3, 2003
Rapid deterioration in quality of life during interleukin-2- and alpha-interferon-based home therapy of renal cell carcinoma is associated with a good outcomeJ Atzpodien, Th Küchler, T Wandert, et al.British Journal of Cancer|June 1, 2006
An approach to estimating prognosis using fractional polynomials in metastatic renal carcinomaP Royston, M Reitz, J AtzpodienBritish Journal of Cancer|March 10, 2005
Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)J Atzpodien, E Schmitt, U Gertenbach, et al.British Journal of Cancer|November 1, 2007
Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patientsJ Atzpodien, K Terfloth, M Fluck, et al.British Journal of Cancer|November 17, 2001
IL-2 in combination with IFN- alpha and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trialJ Atzpodien, H Kirchner, H J Illiger, et al.British Journal of Cancer|March 31, 1999
Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinomaF Wittke, R Hoffmann, J Buer, et al.Cancer Biotherapy & Radiopharmaceuticals|December 10, 2002
Interleukin-12 inhibits apoptosis in chronic lymphatic leukemia (CLL) B cellsS Schuhknecht, S Duensing, I Dallmann, et al.Journal of Cancer Research and Clinical Oncology|October 12, 2012
A nine-gene signature predicting clinical outcome in cutaneous melanomaG Brunner, M Reitz, A Heinecke, et al.Pageof 37